AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 50 filers reported holding AQUINOX PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $10,372,000 | +46.4% | 628,230 | +18.5% | 0.01% | +57.1% |
| Q3 2016 | $7,086,000 | +164.6% | 530,373 | +31.1% | 0.01% | +133.3% |
| Q2 2016 | $2,678,000 | -23.4% | 404,575 | +2.1% | 0.00% | -25.0% |
| Q1 2016 | $3,495,000 | -8.8% | 396,295 | +29.0% | 0.00% | 0.0% |
| Q4 2015 | $3,834,000 | -11.3% | 307,195 | -0.0% | 0.00% | -20.0% |
| Q3 2015 | $4,324,000 | +439.8% | 307,300 | +166.3% | 0.01% | +400.0% |
| Q2 2015 | $801,000 | -15.6% | 115,400 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $949,000 | +11.1% | 115,400 | +1.4% | 0.00% | 0.0% |
| Q4 2014 | $854,000 | +12.2% | 113,800 | -0.4% | 0.00% | 0.0% |
| Q3 2014 | $761,000 | -35.5% | 114,200 | -8.6% | 0.00% | 0.0% |
| Q2 2014 | $1,179,000 | -26.0% | 125,000 | -0.2% | 0.00% | -50.0% |
| Q1 2014 | $1,594,000 | – | 125,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 400,900 | $1,062,000 | 0.78% |
| EMORY UNIVERSITY | 209,207 | $554,000 | 0.37% |
| EcoR1 Capital, LLC | 1,150,000 | $3,048,000 | 0.29% |
| Baker Brothers Advisors | 10,934,154 | $28,976,000 | 0.22% |
| DLD Asset Management, LP | 763,100 | $2,030,000 | 0.15% |
| UNIVERSITY OF NOTRE DAME DU LAC | 214,759 | $569,000 | 0.11% |
| Kalos Management, Inc. | 15,850 | $226,000 | 0.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 257,613 | $683,000 | 0.09% |
| DLD Asset Management, LP | 379,900 | $1,007,000 | 0.08% |
| DLD Asset Management, LP | 379,300 | $1,009,000 | 0.08% |